Orphan drug strategy at NanoViricides shows faster approval for new treatments

By Proactive Investors / February 20, 2026 / www.youtube.com / Article Link

NanoViricides CEO Dr Anil Diwan outlines the next steps for NV-387 as the company prepares to begin Phase 2 dosing for Mpox ...

Recent News

Mining ETF outflows not severe versus December 2025-January 2026 inflows

March 30, 2026 / www.canadianminingreport.com

Gold stocks rebound as metal declines

March 30, 2026 / www.canadianminingreport.com

Energy outperforms gold and tech for first time in years

March 23, 2026 / www.canadianminingreport.com

Gold stocks crash along with metal price

March 23, 2026 / www.canadianminingreport.com

Mining stock ETFs slide, gold sector valuations high

March 16, 2026 / www.canadianminingreport.com

See all >